HOME >> BIOLOGY >> NEWS
OT, VP studied as novel psychiatric drug sources; consider gender-specific drug models

STEAMBOAT SPRINGS, Colorado (July 19, 2005) Physiologists and medical researchers have long recognized the important endocrine roles played by the pituitary hormones oxytocin (OT) and vasopressin (VP) on peripheral systems in lactation, uterine contraction and urine concentration.

Over the past few years, neuroscientists have begun reporting evidence solidifying the possible roles of OT and VP in social behavior, both normal (bonding, romance) and pathological (autism, aggression). In a recent human study, Swiss and American scientists have also reported that intranasal spray containing the hormone oxytocin increases trust between humans by reducing the anxiety of risks that arise through interpersonal interactions.

Robert Ring, a researcher with the Wyeth Discovery Neuroscience group, said that perhaps the time is right for drugmakers to take a closer look at the important roles these two substances play inside the brain. The pharmaceutical industry has been very successful in developing medicines aimed at regulating the hormonal effects of these two pituitary hormones on peripheral systems. Pitocin, an oxytocin-like molecule, was developed and commonly used to induce contractions during birth. Similarly, vasopressin receptors in the kidney and vascular smooth muscle have been targeted for the treatment of heart failure and other diseases.

Drug companies, however, may have "underappreciated the important roles that both the central vasopressinergic and oxytocinergic systems play in modulating neural-circuitry underlying many of the behavioral, neuroendocrine and autonomic features of psychiatric diseases,"

He noted that in the brain, oxytocin and vasopressin are not considered hormones, but act rather as "powerful neurotransmitters, regulating many of the same brain functions that are often disturbed in psychiatric disease." Not surprisingly, drug companies relatively recently have begun to "reexamine their extensive experience w
'"/>


19-Jul-2005


Page: 1 2 3

Related biology news :

1. Bacterial response to oxidation studied as toxin barometer
2. Ground spider diversity studied in research project
3. Fat stem cells being studied as option for breast reconstruction
4. Area creek studied for rangeland effects on water quality
5. Links between DNA damage and breast cancer studied
6. Inflammation and drugs to control this activity studied in a variety of tumors sites
7. Saharas edge studied from ground, air and space to improve water management
8. Atherosclerosis studied at the cellular level
9. Novel biotoxin being studied for use in opioid withdrawal
10. Insecticide resistance in mosquitoes being studied
11. MIT: Recycling of scrapped electronics studied

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2019)... ... August 19, 2019 , ... Since the microscope was ... two dimensional slices which are placed on microscope slides, stained and visualized by ... complicated features such as vasculature and thus researchers in the last few years ...
(Date:8/14/2019)... CITY, and MARTINSRIED, Germany (PRWEB) , ... August ... ... high-throughput antibody screening and characterization, announced today that they have opened a Customer ... platform has fueled the need for the new office. , The Munich CEC ...
(Date:8/14/2019)... ... 13, 2019 , ... Dr. Julie Reck of Veterinary Medical Center of Fort Mill ... first stem cell patient, her own geriatric Australian Shepherd, Simon, was treated in June 2019 ... to play but his body was weak, and he struggled to play fetch and other ...
Breaking Biology News(10 mins):
(Date:6/26/2019)... ... , ... Alice Branton today released research results from preclinical trials on the ... can prove to be beneficial for treating Hypomagnesemia. , The preclinical trial shows:, ... size , Over 142% increase in particle size , Over ...
(Date:6/11/2019)... , ... June 10, 2019 , ... ... its distribution network with the appointment of Biofeedback Tech Ltd as ... systems are an essential part of many therapeutic treatments and clinical assessment protocols ...
(Date:6/11/2019)... (PRWEB) , ... June 11, 2019 , ... ... of Personalized Stem Cells Inc. (PSC) , has announced that their GMP ... Health, Food and Drug Branch for manufacturing. This is an important milestone ...
(Date:5/31/2019)... , ... May 29, 2019 ... ... patent applications from the USPTO providing proprietary interest to our methodology, processes, ... SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights including our proprietary ...
Breaking Biology Technology:
Cached News: